Furthermore, IgE specific to tumour antigens and with tumoricidal properties has been reported in patients with head and neck cancer and pancreatic cancer, in the circulation and tumour tissues [104,105], without anaphylaxis occurring. Here, IGHE is linked to head and neck cancer.